Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30beaaa993ebfd38cfa2df185ff97bb6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43581 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 |
filingDate |
1999-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3596554a2b2407c53a57481b2ae1b42f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d9cf65145a5c22a3ee6be474ca0e447 |
publicationDate |
2003-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
HU-0204199-A2 |
titleOfInvention |
Transport vectors |
abstract |
The present invention relates to modified and truncated forms of the penetratin membrane transport vector. These truncated forms contain peptides containing 7 units and themselves contain further variants. The compounds of the invention are useful for delivering therapeutic agents to target cells. HE |
priorityDate |
1998-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |